Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HTBS (Health Technology Board for Scotland) issues final protocol for foetal ultrasound HTA (health technology assessment):

This article was originally published in Clinica

Executive Summary

The Health Technology Board for Scotland (HTBS) has today (October 10 2002) issued the final protocol for the assessment of routine ultrasound testing in the first 24 weeks of pregnancy. The assessment will address the issues related to offering only a first trimester "booking" scan, only a second trimester "anomaly" scan or a combination of both. It will also assess the routine use of transvaginal scanning in pregnancy and the benefits of routinely using Doppler ultrasound during early pregnancy. The consultation on the draft protocol ended on September 20 2002; the assessment is due to be completed by December 2003 (see Clinica No 1024, p 7).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel